Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Beutel

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|October 27, 2019
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future OutlookNora Möhn, Gernot Beutel, Ralf Gutzmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumorsGernot Beutel, Hilary Glen, Patrick Schöffski, et al.
Critical Care (London, England)|April 15, 2017
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their managementFrank Kroschinsky, Friedrich Stölzel, Simone von Bonin, et al.
BMC Cancer|January 4, 2011
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinibViktor Gruenwald, Gernot Beutel, Susanne Schuch-Jantsch, et al.
Blood|August 17, 2006
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogeneticsMichael Heuser, Gernot Beutel, Juergen Krauter, et al.
The Annals of Thoracic Surgery|May 10, 2011
Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation supportTheodosios Bisdas, Gernot Beutel, Gregor Warnecke, et al.
European Journal of Haematology|September 3, 2011
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndromeStefanie Buchholz, Elke Dammann, Michael Stadler, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 13, 2026
Impact of sampling side of peritoneal biopsies on peritoneal thickness and histopathological diagnosis-A quantitative histological study in body donorsGabriele Eden, Frederick Pfister, Vedat Schwenger, et al.
Clinical Genitourinary Cancer|November 20, 2016
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving SunitinibPhilipp Ivanyi, Gernot Beutel, Nicole Drewes, et al.
Blood Purification|November 23, 2012
New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: a clinical crossover comparison in extended dialysisJulius J Schmidt, Carsten Hafer, Christian Clajus, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|October 27, 2019
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future OutlookNora Möhn, Gernot Beutel, Ralf Gutzmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumorsGernot Beutel, Hilary Glen, Patrick Schöffski, et al.
Critical Care (London, England)|April 15, 2017
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their managementFrank Kroschinsky, Friedrich Stölzel, Simone von Bonin, et al.
BMC Cancer|January 4, 2011
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinibViktor Gruenwald, Gernot Beutel, Susanne Schuch-Jantsch, et al.
Blood|August 17, 2006
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogeneticsMichael Heuser, Gernot Beutel, Juergen Krauter, et al.
The Annals of Thoracic Surgery|May 10, 2011
Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation supportTheodosios Bisdas, Gernot Beutel, Gregor Warnecke, et al.
European Journal of Haematology|September 3, 2011
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndromeStefanie Buchholz, Elke Dammann, Michael Stadler, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 13, 2026
Impact of sampling side of peritoneal biopsies on peritoneal thickness and histopathological diagnosis-A quantitative histological study in body donorsGabriele Eden, Frederick Pfister, Vedat Schwenger, et al.
Clinical Genitourinary Cancer|November 20, 2016
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving SunitinibPhilipp Ivanyi, Gernot Beutel, Nicole Drewes, et al.
Blood Purification|November 23, 2012
New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: a clinical crossover comparison in extended dialysisJulius J Schmidt, Carsten Hafer, Christian Clajus, et al.
Pageof 9